OR Royalties (NYSE:OR) Stock Rating Lowered by Wall Street Zen

OR Royalties (NYSE:OR) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

Other equities research analysts have also issued reports about the stock. Weiss Ratings reaffirmed a “buy (b)” rating on shares of OR Royalties in a report on Friday, May 22nd. Royal Bank Of Canada reissued an “outperform” rating and set a $56.00 target price on shares of OR Royalties in a research note on Friday, April 10th. Zacks Research lowered shares of OR Royalties from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 31st. Finally, TD Securities reissued a “hold” rating on shares of OR Royalties in a research note on Monday, February 23rd. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, OR Royalties presently has a consensus rating of “Moderate Buy” and an average price target of $46.50.

OR Royalties Stock Performance

NYSE:OR opened at $33.81 on Friday. OR Royalties has a one year low of $24.76 and a one year high of $48.06. The firm has a market cap of $6.34 billion, a price-to-earnings ratio of 25.23 and a beta of 0.70. The firm’s fifty day moving average is $38.03 and its two-hundred day moving average is $38.69.

OR Royalties (NYSE:OR) last posted its quarterly earnings results on Wednesday, May 6th. The basic materials company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.34 by $0.06. OR Royalties had a net margin of 78.09% and a return on equity of 15.10%. The company had revenue of $102.83 million for the quarter, compared to analyst estimates of $103.27 million. As a group, equities research analysts predict that OR Royalties will post 1.4 earnings per share for the current fiscal year.

Institutional Investors Weigh In On OR Royalties

Hedge funds have recently modified their holdings of the company. State of Wyoming purchased a new stake in shares of OR Royalties during the 1st quarter worth about $28,000. FIL Ltd purchased a new position in OR Royalties in the 4th quarter valued at about $29,000. Banque Cantonale Vaudoise purchased a new position in OR Royalties in the 1st quarter valued at about $37,000. Assetmark Inc. purchased a new position in OR Royalties in the 4th quarter valued at about $36,000. Finally, Caitlin John LLC purchased a new position in OR Royalties in the 3rd quarter valued at about $78,000. 68.52% of the stock is owned by hedge funds and other institutional investors.

OR Royalties Company Profile

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.